Moseley Investment Management Inc Crispr Therapeutics Ag Transaction History

Moseley Investment Management Inc

  • $199 Million
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 25, 2022
SELL
$70.09 - $111.29 $186,789 - $296,587
-2,665 Closed
0 $0
Q3 2021

Oct 27, 2021
BUY
$110.2 - $156.64 $7,603 - $10,808
69 Added 2.66%
2,665 $297,000
Q2 2021

Aug 11, 2021
BUY
$100.84 - $161.89 $27,125 - $43,548
269 Added 11.56%
2,596 $420,000
Q1 2021

Apr 19, 2021
BUY
$110.72 - $210.04 $55,027 - $104,389
497 Added 27.16%
2,327 $284,000
Q4 2020

Jan 26, 2021
BUY
$79.67 - $173.23 $145,796 - $317,010
1,830 New
1,830 $280,000

Others Institutions Holding CRSP

# of Institutions
550
Shares Held
56.3M
Call Options Held
2.91M
Put Options Held
2.47M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $4.15B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Moseley Investment Management Inc Portfolio

Follow Moseley Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moseley Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Moseley Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email